Repligen (RGEN) Cash & Current Investments (2010 - 2026)

Repligen (RGEN) has 17 years of Cash & Current Investments data on file, last reported at $986.4 million in Q1 2026.

• On a quarterly basis, Cash & Current Investments rose 41.48% year-over-year to $986.4 million in Q1 2026; TTM through Mar 2026 was $986.4 million, a 41.48% increase from a year earlier, with the FY2025 full-year figure at $969.2 million, up 27.98% from the prior year.
• Cash & Current Investments for Q1 2026 stood at $986.4 million, up from $969.2 million in the prior quarter.
• Over the last five years, Cash & Current Investments for RGEN reached as high as $986.4 million in Q1 2026 and fell as low as $573.4 million in Q3 2022.
• Historically, Cash & Current Investments has averaged $719.0 million across 5 years, with a median of $708.9 million in 2025.
• Across the five-year window, Cash & Current Investments decreased 18.77% in 2022 and soared 41.48% in 2026, its largest moves.
• Year by year, Cash & Current Investments stood at $623.8 million in 2022, then grew by 20.45% to $751.3 million in 2023, then rose by 0.8% to $757.4 million in 2024, then increased by 27.98% to $969.2 million in 2025, then advanced by 1.77% to $986.4 million in 2026.
• Per Business Quant data, the three most recent Cash & Current Investments figures were $986.4 million in Q1 2026, $969.2 million in Q4 2025, and $748.7 million in Q3 2025.